公开(公告)号：US20140335134A1

公开(公告)日：2014-11-13

申请号：US14337949

申请日：2014-07-22

申请人： Feng Chia University

发明人： Tse-Hao Ko ,  Chen-Li Cheng ,  Ming-Chean Hung ,  Sheau-Yun Yuan ,  Shih-I Chang

IPC分类号： A61K33/44 ,  A61K45/06 ,  A61K9/14 ,  A61K9/10 ,  A61K33/38

CPC分类号： A61K33/44 ,  A61K9/0034 ,  A61K9/10 ,  A61K9/14 ,  A61K33/24 ,  A61K33/30 ,  A61K33/34 ,  A61K33/38 ,  A61K45/06 ,  A61K2300/00

摘要： A method for treating urinary system disorders comprising: a pharmaceutical composition comprising a carbon material and a water-containing carrier, the pharmaceutical composition comprising a carbon material in an amount from 0.001 mgs to 100 mgs, both of the carbon material and the water-containing carrier constitute a pharmaceutically acceptable water-containing carrier carrying the carbon material, and the carbon material having a diameter falling within a range from 2 nm to 2 mm; Then instilled this pharmaceutical composition into the bladder for adsorb LPS of bacteria, aqueous vehicle in a volume of from 50 mL to 700 mL. After adsorb, discharging the LPS together with urine out of cystitis patients. This method is capable of reducing symptoms of cystitis by contacting the carbon material with a bladder or related tissues of the bladder in an animal body.

摘要翻译： 一种治疗泌尿系统疾病的方法，包括：包含碳材料和含水载体的药物组合物，所述药物组合物包含0.001mg至100mg的碳材料，所述碳材料和含水的 载体构成携带碳材料的药学上可接受的含水载体，直径在2nm至2mm的范围内的碳材料; 然后将该药物组合物滴入膀胱中以吸收细菌的LPS，水溶媒体体积为50mL至700mL。 吸收后，将LPS与尿液一起排出膀胱炎患者。 该方法能够通过使碳材料与动物体内的膀胱或膀胱的相关组织接触来减少膀胱炎的症状。

公开(公告)号：US09132151B2

公开(公告)日：2015-09-15

申请号：US14337949

申请日：2014-07-22

申请人： Feng Chia University

发明人： Tse-Hao Ko ,  Chen-Li Cheng ,  Ming-Chean Hung ,  Sheau-Yun Yuan ,  Shih-I Chang

IPC分类号： A61K9/00 ,  A61K33/44 ,  A61K33/38 ,  A61K33/34 ,  A61K9/10 ,  A61K33/24 ,  A61K33/30 ,  A61K9/14 ,  A61K45/06

CPC分类号： A61K33/44 ,  A61K9/0034 ,  A61K9/10 ,  A61K9/14 ,  A61K33/24 ,  A61K33/30 ,  A61K33/34 ,  A61K33/38 ,  A61K45/06 ,  A61K2300/00

摘要： A method for treating urinary system disorders comprising: a pharmaceutical composition comprising a carbon material and a water-containing carrier, the pharmaceutical composition comprising a carbon material in an amount from 0.001 mgs to 100 mgs, both of the carbon material and the water-containing carrier constitute a pharmaceutically acceptable water-containing carrier carrying the carbon material, and the carbon material having a diameter falling within a range from 2 nm to 2 mm; Then instilled this pharmaceutical composition into the bladder for adsorb LPS of bacteria, aqueous vehicle in a volume of from 50 mL to 700 mL. After adsorb, discharging the LPS together with urine out of cystitis patients. This method is capable of reducing symptoms of cystitis by contacting the carbon material with a bladder or related tissues of the bladder in an animal body.

摘要翻译： 一种治疗泌尿系统疾病的方法，包括：包含碳材料和含水载体的药物组合物，所述药物组合物包含0.001mg至100mg的碳材料，所述碳材料和含水的 载体构成携带碳材料的药学上可接受的含水载体，直径在2nm至2mm的范围内的碳材料; 然后将该药物组合物滴入膀胱中以吸收细菌的LPS，水溶媒体体积为50mL至700mL。 吸收后，将LPS与尿液一起排出膀胱炎患者。 该方法能够通过使碳材料与动物体内的膀胱或膀胱的相关组织接触来减少膀胱炎的症状。